I believe the disclosure is something they have to write so

New Post Public Reply Private Reply Replies (2) Message Board
craigakess TechGuru #19996
538
I believe the disclosure is something they have to write so that people know if this is a biased article or not, and if it was paid for by the company or not. Hell, the way some here throw around "IMO" at every wrong moment...

But the thing is, I cannot disagree with a lot of what the writer said. CYDY is a tiny company run by somewhat inept management. YES, I get it, they have done an ok job so far, but they are paying themselves EXORBITANT salaries for a broke company that has made $0 and has over promised and under delivered for years now...unless of course you believe that the ends justify the means. I don't. That's dangerous.

I don't think that CYDY has the talent onboard to negotiate the major deals that they will need to make, since they are too small to go it alone in any indication. Vyera? As I have said, a dog with fleas. And, as also used by the author of the article, I used the "If you can't dazzle them with brilliance..." line a few days ago in a post about what this upcoming CC may be.

Don't get me wrong, I am long and strong CYDY for a few years now, but I am also not drinking the proverbial KoolAid. While I do believe in the science 100%, I only believe in the management 50%. If YOU wrote a business plan that had projections of zero revenue for years, but said you wanted a huge 7 figure salary that would hamstring the company, most people would probably not fund your business, wanting you to invest in yourself first if they are supposed to invest in you. Build into your contract bonuses in the event of success. But even if CYDY fails, NP and the board are rich men now, thanks to the shareholders who have tried to make themselves believe that "this time, NP's really going to do it!"

Over a year ago, CYDY hired people we thought were coming onboard because of their negotiating skills. If true, we haven't needed them and that's just sad. As I have said, investors and BP are not stupid in general. Good investors are not emotionally involved with their investments, but I think many here are emotionally invested in CYDY, which is why NP cannot be questioned by many here, because "Once we get approval, all is forgiven!" but to me, that is just not true. Look at what Nick Woodman, founder and CEO, did to GoPro. Took it from nothing, to $95/share right back down to $3.60/share where it is today. He cannot get out of his own way due to pride. He has a yacht. Shareholders have a sea of red.

If this conference call is just a dog and pony show with nothing materially new being said (and not just "We are in talks!" then while I still believe in the science, I will think it is time for someone who can really take CYDY to the next level to come in and help. Just because I could play high school baseball doesn't mean I was good enough to make the next level in college.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

Updated Category News Views 24

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Continue Reading
New Study Exposes Grim Reality for Moderate Aortic Stenosis

Updated Category News Views 86

Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...

Continue Reading
Xylitol: A Game Changer in Kids' Oral Care Battle

Updated Category News Views 91

Candy Challenges: Embracing Sweet Joys Responsibly Think you're done with Halloween? Nope. Welcome to the endless candy seasons when every festivity seems like an outlet for sugar overload—with parents caught between letting kids enjoy and guarding their teeth. Now, with Spry's recent push around xylitol, there's an option that might just mean an easier peace between...

Continue Reading
ATS Energy Adds Shell Veteran to Fuel Big Ambitions

Updated Category News Views 107

ATS Energy: Charging Ahead with New Leadership There's nothing quite like the spark of new leadership to rev up the energy sector, and ATS Energy—fresh off its Earthshot Prize win—has just thrown in a turbocharged trio. Bringing in seasoned pros with stacks of industrial technology, finance, and infrastructure chops, this isn't your run-of-the-mill board shakeup. It's...

Continue Reading
Atlanta's Rental Dilemma: Supply High, Approvals Low

Updated Category News Views 88

Here's a head-scratcher for you: Atlanta just cranked out apartment buildings like they were goin' outta style, yet folks with cash in hand can't get a foot in the door. With a whopping 10.9% vacancy rate, you'd think they'd be rolling out the welcome mat. But oh no, what's actually playing gatekeeper is our ol' buddy, the credit score. Plenty of Apartments, Not Enough...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 29

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Rana Gillmon Takes on Bigger Role at AXA XL

Updated Category News Views 42

Leadership Leap for Rana Gillmon Well, we've got some buzz from AXA XL that's stirring the pot in the insurance scene, with Rana Gillmon taking on a more expansive role. She's now at the helm of client and distribution activities in the East Zone of the U.S. alongside her existing responsibilities in private equity client relations across the Americas. Sounds like a hefty...

Continue Reading
Ally Financial Scores High Marks: Banking and Workplace

Updated Category News Views 78

Ally's Impressive Award Sweep Takes the Spotlight There's something palpable about consistently being on top of the game in a sector as cutthroat as banking. Ally Financial is turning heads with a series of recognitions that paint a picture of a company doing more than just crunching numbers under the ticker NYSE:ALLY. Why Ally Bank Tops the Banking Charts Ally's been...

Continue Reading
Michael Schade Joins LIU as VP and General Counsel

Updated Category News Views 62

Shaping the Future with a Legal Vet Michael Schade slipping into the VP and General Counsel chair at Long Island University isn't just another nameplate shuffle. It's a solid move for a university looking to tighten its grip on being a major research player. A Power Player from the University of Oklahoma Schade isn't new to the world of academic law. He's packing legal...

Continue Reading
Hunan Courts European Investors with Strategic Initiatives

Updated Category News Views 58

Seizing the European Spotlight You've heard of places making a splash, but Hunan smashing through the scene in Europe? Now that's a move you don't see every day. This Chinese province is dead set on stealing the European investment show, with a slick meet-and-greet tour across Germany and Switzerland. What's cooking in Hunan isn't your typical rice porridge—it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Hilco Global Appoints New Executive to Boost Real Estate Advisory

Updated Category News Views 142

Hilco Global Expands Real Estate Advisory with New Leadership Hilco Global is excited to welcome Mitch Friedel as the new Executive Director of Retail Development Advisory and Leasing within its Real Estate Advisory practice. This key appointment reflects the company's dedication to enhancing its Professional Services division, as it seek to increase capabilities in the...

Continue Reading
U.S. Employment Gains Surge: ADP's Latest Insights

Updated Category News Views 93

Current Trends in U.S. Employment In a recent update, reports highlight that for a four-week period, U.S. private employers are creating jobs at a steady pace. According to the latest ADP employment report, an average of 11,750 jobs were added each week. This information sheds light on the resilience of the job market, despite the economic challenges that have emerged in...

Continue Reading
Investors Warned of Upcoming Deadline in WM Technology Case

Updated Category News Views 195

Investors Alerted to Key Filing Deadline for WM Technology The Law Offices of Frank R. Cruz have issued an important reminder to investors regarding a significant deadline in the class action lawsuit against WM Technology, Inc. (NASDAQ: MAPS). Investors who purchased securities of WM Technology between certain dates are urged to take note of the approaching lead plaintiff...

Continue Reading
Atlas Air Snags 49% Stake in Air Atlanta: Strategic Dive

Updated Category News Views 21

Atlas Air's New Move in Aviation Logistics Atlas Air Worldwide, that heavyweight in the world of aviation logistics, just finished buttoning up a strategic play that’s caught my eye — a chunky 49% stake in Air Atlanta. It’s not just about numbers; it’s Atlas flexing to expand its footprint where it matters. Diving Into the Deal You know what had me scratching my...

Continue Reading
Dr. Rod J. Rohrich Named Top Rhinoplasty Surgeon Again

Updated Category News Views 257

Dr. Rod J. Rohrich: A Leader in Rhinoplasty Renowned plastic surgeon Dr. Rod J. Rohrich has once again made headlines by being recognized as the premier rhinoplasty expert in the country for the fifth consecutive year. This accolade comes from a prestigious ranking published in Newsweek, reiterating Dr. Rohrich's commitment to excellence in the field of plastic surgery....

Continue Reading